These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25341357)

  • 1. The role of cardiotonic steroids in the pathogenesis of cardiomyopathy in chronic kidney disease.
    Pavlovic D
    Nephron Clin Pract; 2014; 128(1-2):11-21. PubMed ID: 25341357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous cardiotonic steroids and cardiovascular disease, where to next?
    Pavlovic D
    Cell Calcium; 2020 Mar; 86():102156. PubMed ID: 31896530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
    Schoner W; Scheiner-Bobis G
    Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of endogenous cardiotonic steroids in pathogenesis of cardiovascular and renal complications of arterial hypertension.
    Paczula A; Więcek A; Piecha G
    Postepy Hig Med Dosw (Online); 2016 Mar; 70():243-50. PubMed ID: 27117099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation.
    Touza NA; Pôças ES; Quintas LE; Cunha-Filho G; Santos ML; Noël F
    Life Sci; 2011 Jan; 88(1-2):39-42. PubMed ID: 21047518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in understanding the role of cardiac glycosides in control of sodium transport in renal tubules.
    Khundmiri SJ
    J Endocrinol; 2014 Jul; 222(1):R11-24. PubMed ID: 24781255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
    Schoner W; Scheiner-Bobis G
    Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous cardiotonic steroids.
    Schoner W
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):273-80. PubMed ID: 11355001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.
    Bagrov AY; Shapiro JI; Fedorova OV
    Pharmacol Rev; 2009 Mar; 61(1):9-38. PubMed ID: 19325075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry and the Potential Antiviral, Anticancer, and Anti-Inflammatory Activities of Cardiotonic Steroids Derived from Toads.
    El-Seedi HR; Yosri N; El-Aarag B; Mahmoud SH; Zayed A; Du M; Saeed A; Musharraf SG; El-Garawani IM; Habib MR; Tahir HE; Hegab MM; Zou X; Guo Z; Efferth T; Khalifa SAM
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New steroid hormone family: endogenous cardiac glycosides and their role in physiologic and pathologic conditions].
    Somogyi J; Szalay J; Pándics T; Rosta K; Csermely P; Vér A
    Orv Hetil; 2004 Feb; 145(6):259-66. PubMed ID: 15038319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
    Cornelius F; Mahmmoud YA
    Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway.
    Arnaud-Batista FJ; Costa GT; Oliveira IM; Costa PP; Santos CF; Fonteles MC; Uchôa DE; Silveira ER; Cardi BA; Carvalho KM; Amaral LS; Pôças ES; Quintas LE; Noël F; Nascimento NR
    Am J Physiol Renal Physiol; 2012 Apr; 302(8):F959-66. PubMed ID: 22237798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular insights into uremic cardiomyopathy: cardiotonic steroids and Na/K ATPase signaling.
    Kennedy DJ; Malhotra D; Shapiro JI
    Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):3-14. PubMed ID: 17535729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of the bufadienolides in cardiovascular and kidney diseases.
    Puschett JB; Agunanne E; Uddin MN
    Am J Kidney Dis; 2010 Aug; 56(2):359-70. PubMed ID: 20417001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous Mammalian Cardiotonic Steroids-A New Cardiovascular Risk Factor?-A Mini-Review.
    Słabiak-Błaż N; Piecha G
    Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physiological and clinical importance of sodium potassium ATPase in cardiovascular diseases.
    Yan Y; Shapiro JI
    Curr Opin Pharmacol; 2016 Apr; 27():43-9. PubMed ID: 26891193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis.
    Hamlyn JM; Manunta P
    Adv Chronic Kidney Dis; 2015 May; 22(3):232-44. PubMed ID: 25908473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Na/K-ATPase endocytosis couples pumping and leaking activities in renal epithelial cells: a hypothesis.
    Liu J
    Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):97-104. PubMed ID: 17535743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia.
    Oselkin M; Tian D; Bergold PJ
    Neurosci Lett; 2010 Apr; 473(2):67-71. PubMed ID: 19822191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.